跳至主要内容
临床试验/NCT06408779
NCT06408779已完成不适用

Study on Surgical Treatment Strategies for Moderate Ischemic Mitral Regurgitation

China National Center for Cardiovascular Diseases1 个研究点 分布在 1 个国家目标入组 464 人开始时间: 2023年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
464
试验地点
1
主要终点
major adverse cardiovascular and cerebrovascular events

研究概览

简要总结

This study aimed to compare the efficacy of isolated coronary artery bypass grafting and coronary artery bypass grafting + mitral valve repair in moderate ischemic mitral regurgitation patients through a cohort and explore the potential risk factors of the clinical outcomes.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult coronary artery disease patients complicated with moderate ischemic mitral regurgitation.
  • undergoing coronary artery bypass grafting with or without mitral valve repair.

排除标准

  • patients under the age of 18 years,
  • patients complicated with more than moderate ischemic mitral regurgitation or undergoing mitral valve replacement,
  • patients complicated with primary mitral valve disease other than ischemic mitral regurgitation, such as rheumatic mitral regurgitation or mitral valve leaflet prolapse,
  • patients undergoing concomitant aortic valve procedure.

结局指标

主要结局

major adverse cardiovascular and cerebrovascular events

时间窗: 2years

the composite of all-cause death, rehospitalization for heart failure, non-fatal myocardial infarction, non-fatal stroke or repeat mitral valve surgery.

次要结局

未报告次要终点

研究者

发起方
China National Center for Cardiovascular Diseases
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Study on Surgical Treatment Strategies for Moderate... | 临床试验